Skip to main content

Advertisement

SpringerLink
Log in

Diabetic Foot Infections: Update on Management

  • Skin, Soft Tissue, Bone and Joint Infectious Disease (N Safdar and A Pop-Vicas, Section Editors)
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Diabetic foot infections (DFIs) are common in patients with diabetes mellitus complicated by foot ulcers and can be classified in different categories based on their severity. In this report, we present the diagnosis and management of DFIs according to their classification.

Recent Findings

While appropriate antibiotic regiments and surgical techniques for the treatment of DFIs are well established, new technologies and techniques for example in medical imaging, wound care modalities, and supplementary therapy approaches show potentially promising results in preventing DFIs.

Summary

As with every complex disease, fine tuning DFI management can be challenging as it requires careful evaluation of different parameters. It demands timely action, close collaboration of different specialties, and patient cooperation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Raspovic KM, Wukich DK. Self-reported quality of life and diabetic foot infections. J Foot Ankle Surg. 2014;53(6):716–9. https://doi.org/10.1053/j.jfas.2014.06.011.

    Article  PubMed  Google Scholar 

  2. Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826–34. https://doi.org/10.1007/s00125-008-1089-6.

    Article  PubMed  CAS  Google Scholar 

  3. Morbach S, Furchert H, Groblinghoff U, Hoffmeier H, Kersten K, Klauke GT, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021–7. https://doi.org/10.2337/dc12-0200.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Peters EJ, Lipsky BA. Diagnosis and management of infection in the diabetic foot. Med Clin N Am. 2013;97(5):911–46. https://doi.org/10.1016/j.mcna.2013.04.005.

    Article  PubMed  Google Scholar 

  5. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288–93. https://doi.org/10.2337/dc05-2425.

    Article  PubMed  Google Scholar 

  6. • Lipsky BA, Aragon-Sanchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):45–74. https://doi.org/10.1002/dmrr.2699. This is an important article describing the recommendations of the International Working Group on The Diabetic Foot for the diagnosis, classification of the severity, and management of diabetic foor infections.

    Article  PubMed  Google Scholar 

  7. • Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132–73. https://doi.org/10.1093/cid/cis346. This article describes the Infectious Diseases Society of America clinical practice guidelines for the diagnosis and treatment of diabetic foot infections. The reader can find useful information for the diagnosis, classification, and management of diabetic foot infections.

    Article  PubMed  Google Scholar 

  8. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14. https://doi.org/10.1002/dmrr.2239.

    Article  PubMed  Google Scholar 

  9. American Diabetes A. 10. Microvascular complications and foot care. Diabetes Care. 2017;40(Suppl 1):S88–98. https://doi.org/10.2337/dc17-S013.

    Article  Google Scholar 

  10. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–54. https://doi.org/10.2337/dc16-2042.

    Article  PubMed  CAS  Google Scholar 

  11. Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K, International Working Group on the Diabetic F. Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents. Diabetes Metab Res Rev. 2016;32(Suppl 1):7–15. https://doi.org/10.1002/dmrr.2695.

    Article  PubMed  Google Scholar 

  12. Garwood CS, Steinberg JS. What's new in wound treatment: a critical appraisal. Diabetes Metab Res Rev. 2016;32(Suppl 1):268–74. https://doi.org/10.1002/dmrr.2747.

    Article  PubMed  Google Scholar 

  13. Lewis J, Lipp A. Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2013;1:CD002302. https://doi.org/10.1002/14651858.CD002302.pub2.

    Article  Google Scholar 

  14. Price P. How can we improve adherence? Diabetes Metab Res Rev. 2016;32(Suppl 1):201–5. https://doi.org/10.1002/dmrr.2744.

    Article  PubMed  Google Scholar 

  15. American Diabetes A. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37(Suppl 1):S14–80. https://doi.org/10.2337/dc14-S014.

    Article  Google Scholar 

  16. Karthikesalingam A, Holt PJ, Moxey P, Jones KG, Thompson MM, Hinchliffe RJ. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med. 2010;27(5):544–9. https://doi.org/10.1111/j.1464-5491.2010.02989.x.

    Article  PubMed  CAS  Google Scholar 

  17. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004;20(Suppl 1):S90–5. https://doi.org/10.1002/dmrr.464.

    Article  PubMed  Google Scholar 

  18. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system. Clin Infect Dis. 2007;44(4):562–5. https://doi.org/10.1086/511036.

    Article  PubMed  Google Scholar 

  19. Peters BM, Jabra-Rizk MA, O’May GA, Costerton JW, Shirtliff ME. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev. 2012;25(1):193–213. https://doi.org/10.1128/CMR.00013-11.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sapico FL, Witte JL, Canawati HN, Montgomerie JZ, Bessman AN. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis. 1984;6(Suppl 1):S171–6.

    Article  PubMed  Google Scholar 

  21. Charles PG, Uckay I, Kressmann B, Emonet S, Lipsky BA. The role of anaerobes in diabetic foot infections. Anaerobe. 2015;34:8–13. https://doi.org/10.1016/j.anaerobe.2015.03.009.

    Article  PubMed  CAS  Google Scholar 

  22. Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. 1999;16(9):767–71.

    Article  PubMed  CAS  Google Scholar 

  23. Ge Y, MacDonald D, Hait H, Lipsky B, Zasloff M, Holroyd K. Microbiological profile of infected diabetic foot ulcers. Diabet Med. 2002;19(12):1032–4.

    Article  PubMed  CAS  Google Scholar 

  24. Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54(1):58–64. https://doi.org/10.1007/s00125-010-1893-7.

    Article  PubMed  CAS  Google Scholar 

  25. Uckay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab. 2014;16(4):305–16. https://doi.org/10.1111/dom.12190.

    Article  PubMed  CAS  Google Scholar 

  26. Uckay I, Aragon-Sanchez J, Lew D, Lipsky BA. Diabetic foot infections: what have we learned in the last 30 years? Int J Infect Dis. 2015;40:81–91. https://doi.org/10.1016/j.ijid.2015.09.023.

    Article  PubMed  Google Scholar 

  27. Lavigne JP, Sotto A, Dunyach-Remy C, Lipsky BA. New molecular techniques to study the skin microbiota of diabetic foot ulcers. Adv Wound Care (New Rochelle). 2015;4(1):38–49. https://doi.org/10.1089/wound.2014.0532.

    Article  Google Scholar 

  28. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med. 2004;21(7):710–5. https://doi.org/10.1111/j.1464-5491.2004.01237.x.

    Article  PubMed  CAS  Google Scholar 

  29. • Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010;70(14):1785–97. https://doi.org/10.2165/11538070-000000000-00000. This review article underlines the problem of the diabetic foot infections caused by multidrug resistance organisms and the ways for prevention and management.

    Article  PubMed  CAS  Google Scholar 

  30. Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006;12(2):186–9. https://doi.org/10.1111/j.1469-0691.2005.01279.x.

    Article  PubMed  CAS  Google Scholar 

  31. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35(4):280–3.

    Article  PubMed  CAS  Google Scholar 

  32. Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med. 2007;213(4):305–12.

    Article  PubMed  CAS  Google Scholar 

  33. Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia. 2008;51(2):347–52. https://doi.org/10.1007/s00125-007-0840-8.

    Article  PubMed  CAS  Google Scholar 

  34. Park JH, Suh DH, Kim HJ, Lee YI, Kwak IH, Choi GW. Role of procalcitonin in infected diabetic foot ulcer. Diabetes Res Clin Pract. 2017;128:51–7. https://doi.org/10.1016/j.diabres.2017.04.008.

    Article  PubMed  CAS  Google Scholar 

  35. Grigoropoulou P, Eleftheriadou I, Jude EB, Tentolouris N. Diabetic foot infections: an update in diagnosis and management. Curr Diab Rep. 2017;17(1):3. https://doi.org/10.1007/s11892-017-0831-1.

    Article  PubMed  Google Scholar 

  36. Akbari R, Javaniyan M, Fahimi A, Sadeghi M. Renal function in patients with diabetic foot infection; does antibiotherapy affect it? J Renal Inj Prev. 2017;6(2):117–21. https://doi.org/10.15171/jrip.2017.23.

    Article  PubMed  CAS  Google Scholar 

  37. Peterson N, Widnall J, Evans P, Jackson G, Platt S. Diagnostic imaging of diabetic foot disorders. Foot Ankle Int. 2017;38(1):86–95. https://doi.org/10.1177/1071100716672660.

    Article  PubMed  Google Scholar 

  38. Nelson EA, Backhouse MR, Bhogal MS, Wright-Hughes A, Lipsky BA, Nixon J, et al. Concordance in diabetic foot ulcer infection. BMJ Open. 2013;3(1):e002370. https://doi.org/10.1136/bmjopen-2012-002370.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Bonham PA. Swab cultures for diagnosing wound infections: a literature review and clinical guideline. J Wound Ostomy Continence Nurs. 2009;36(4):389–95. https://doi.org/10.1097/WON.0b013e3181aaef7f.

    Article  PubMed  Google Scholar 

  40. Sapico FL, Canawati HN, Witte JL, Montgomerie JZ, Wagner FW Jr, Bessman AN. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol. 1980;12(3):413–20.

    PubMed  PubMed Central  CAS  Google Scholar 

  41. Slater RA, Lazarovitch T, Boldur I, Ramot Y, Buchs A, Weiss M, et al. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med. 2004;21(7):705–9. https://doi.org/10.1111/j.1464-5491.2004.01221.x.

    Article  PubMed  CAS  Google Scholar 

  42. Pellizzer G, Strazzabosco M, Presi S, Furlan F, Lora L, Benedetti P, et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med. 2001;18(10):822–7.

    Article  PubMed  CAS  Google Scholar 

  43. Kalish J, Hamdan A. Management of diabetic foot problems. J Vasc Surg. 2010;51(2):476–86. https://doi.org/10.1016/j.jvs.2009.08.043.

    Article  PubMed  Google Scholar 

  44. Jude EB, Unsworth PF. Optimal treatment of infected diabetic foot ulcers. Drugs Aging. 2004;21(13):833–50.

    Article  PubMed  Google Scholar 

  45. Lipsky BA. Diabetic foot infections: current treatment and delaying the ‘post-antibiotic era’. Diabetes Metab Res Rev. 2016;32(Suppl 1):246–53. https://doi.org/10.1002/dmrr.2739.

    Article  PubMed  Google Scholar 

  46. Selva Olid A, Sola I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database Syst Rev. 2015;9:CD009061. https://doi.org/10.1002/14651858.CD009061.pub2.

    Article  Google Scholar 

  47. Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis. 2009;49(10):1541–9. https://doi.org/10.1086/644732.

    Article  PubMed  Google Scholar 

  48. Moura LI, Dias AM, Carvalho E, de Sousa HC. Recent advances on the development of wound dressings for diabetic foot ulcer treatment—a review. Acta Biomater. 2013;9(7):7093–114. https://doi.org/10.1016/j.actbio.2013.03.033.

    Article  PubMed  CAS  Google Scholar 

  49. Armstrong DG, Lavery LA, Diabetic Foot Study C. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366(9498):1704–10. https://doi.org/10.1016/S0140-6736(05)67695-7.

    Article  PubMed  Google Scholar 

  50. Armstrong DG, Lavery LA, Boulton AJ. Negative pressure wound therapy via vacuum-assisted closure following partial foot amputation: what is the role of wound chronicity? Int Wound J. 2007;4(1):79–86. https://doi.org/10.1111/j.1742-481X.2006.00270.x.

    Article  PubMed  Google Scholar 

  51. Kim PJ, Attinger CE, Steinberg JS, Evans KK, Powers KA, Hung RW, et al. The impact of negative-pressure wound therapy with instillation compared with standard negative-pressure wound therapy: a retrospective, historical, cohort, controlled study. Plast Reconstr Surg. 2014;133(3):709–16. https://doi.org/10.1097/01.prs.0000438060.46290.7a.

    Article  PubMed  CAS  Google Scholar 

  52. Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33(5):998–1003. https://doi.org/10.2337/dc09-1754.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;6:CD004123. https://doi.org/10.1002/14651858.CD004123.pub4.

    Article  Google Scholar 

  54. Cazander G, Pawiroredjo JS, Vandenbroucke-Grauls CM, Schreurs MW, Jukema GN. Synergism between maggot excretions and antibiotics. Wound Repair Regen. 2010;18(6):637–42. https://doi.org/10.1111/j.1524-475X.2010.00625.x.

    Article  PubMed  Google Scholar 

  55. Sun X, Jiang K, Chen J, Wu L, Lu H, Wang A, et al. A systematic review of maggot debridement therapy for chronically infected wounds and ulcers. Int J Infect Dis. 2014;25:32–7. https://doi.org/10.1016/j.ijid.2014.03.1397.

    Article  PubMed  Google Scholar 

  56. Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev. 2013;8:CD006810. https://doi.org/10.1002/14651858.CD006810.pub3.

    Article  Google Scholar 

  57. Wukich DK, Hobizal KB, Brooks MM. Severity of diabetic foot infection and rate of limb salvage. Foot Ankle Int. 2013;34(3):351–8. https://doi.org/10.1177/1071100712467980.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Aragon-Sanchez J. Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds. 2011;10(1):33–65. https://doi.org/10.1177/1534734611400259.

    Article  PubMed  Google Scholar 

  59. Lavery LA, Peters EJ, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract. 2009;83(3):347–52. https://doi.org/10.1016/j.diabres.2008.11.030.

    Article  PubMed  Google Scholar 

  60. Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008;24(Suppl 1):S145–61. https://doi.org/10.1002/dmrr.836.

    Article  PubMed  Google Scholar 

  61. Lam K, van Asten SA, Nguyen T, La Fontaine J, Lavery LA. Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review. Clin Infect Dis. 2016;63(7):944–8. https://doi.org/10.1093/cid/ciw445.

    Article  PubMed  Google Scholar 

  62. Senneville E. Editorial commentary: probe-to-bone test for detecting diabetic foot osteomyelitis: rapid, safe, and accurate-but for which patients? Clin Infect Dis. 2016;63(7):949–50. https://doi.org/10.1093/cid/ciw450.

    Article  PubMed  Google Scholar 

  63. Victoria van Asten SA, Geradus Peters EJ, Xi Y, Lavery LA. The role of biomarkers to diagnose diabetic foot osteomyelitis. A meta-analysis. Curr Diabetes Rev. 2016;12(4):396–402.

    Article  PubMed  CAS  Google Scholar 

  64. Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc. 2001;91(9):445–50.

    Article  PubMed  CAS  Google Scholar 

  65. Ertugrul BM, Savk O, Ozturk B, Cobanoglu M, Oncu S, Sakarya S. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med Sci Monit. 2009;15(6):CR307–12.

    PubMed  Google Scholar 

  66. Michail M, Jude E, Liaskos C, Karamagiolis S, Makrilakis K, Dimitroulis D, et al. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds. 2013;12(2):94–9. https://doi.org/10.1177/1534734613486152.

    Article  PubMed  CAS  Google Scholar 

  67. Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008;47(4):519–27. https://doi.org/10.1086/590011.

    Article  PubMed  Google Scholar 

  68. Schinabeck MK, Johnson JL. Osteomyelitis in diabetic foot ulcers. Prompt diagnosis can avert amputation. Postgrad Med. 2005;118(1):11–5.

    Article  PubMed  Google Scholar 

  69. Ertugrul BM, Lipsky BA, Savk O. Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem. Diabet Foot Ankle. 2013;4 https://doi.org/10.3402/dfa.v4i0.21855.

  70. Hartemann-Heurtier A, Senneville E. Diabetic foot osteomyelitis. Diabete Metab. 2008;34(2):87–95. https://doi.org/10.1016/j.diabet.2007.09.005.

    Article  PubMed  CAS  Google Scholar 

  71. • Basu S, Chryssikos T, Houseni M, Scot Malay D, Shah J, Zhuang H, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot’s neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun. 2007;28(6):465–72. https://doi.org/10.1097/MNM.0b013e328174447f. This is a novel study describing the performance of various methods, including FDG PET scan for the differemtial diagnosis of osteomyelitis and Charcot foot.

    Article  PubMed  Google Scholar 

  72. Lipsky BA, Peters EJ, Senneville E, Berendt AR, Embil JM, Lavery LA, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012;28(Suppl 1):163–78. https://doi.org/10.1002/dmrr.2248.

    Article  PubMed  Google Scholar 

  73. Peters EJ. Pitfalls in diagnosing diabetic foot infections. Diabetes Metab Res Rev. 2016;32(Suppl 1):254–60. https://doi.org/10.1002/dmrr.2736.

    Article  PubMed  Google Scholar 

  74. Lazaro-Martinez JL, Aragon-Sanchez J, Garcia-Morales E. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care. 2014;37(3):789–95. https://doi.org/10.2337/dc13-1526.

    Article  PubMed  Google Scholar 

  75. Lesens O, Desbiez F, Theis C, Ferry T, Bensalem M, Laurichesse H, et al. Staphylococcus aureus-related diabetic osteomyelitis: medical or surgical management? A French and Spanish retrospective cohort. Int J Low Extrem Wounds. 2015;14(3):284–90. https://doi.org/10.1177/1534734614559931.

    Article  PubMed  Google Scholar 

  76. Widatalla AH, Mahadi SE, Shawer MA, Mahmoud SM, Abdelmageed AE, Ahmed ME. Diabetic foot infections with osteomyelitis: efficacy of combined surgical and medical treatment. Diabet Foot Ankle. 2012;3 https://doi.org/10.3402/dfa.v3i0.18809.

  77. Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32(Suppl 1):195–200. https://doi.org/10.1002/dmrr.2738.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 17 Agiou Thoma Street, Athens, Greece

    Maria Nikoloudi, Ioanna Eleftheriadou, Anastasios Tentolouris, Ourania A. Kosta & Nikolaos Tentolouris

Authors
  1. Maria Nikoloudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ioanna Eleftheriadou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anastasios Tentolouris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ourania A. Kosta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nikolaos Tentolouris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nikolaos Tentolouris.

Ethics declarations

Conflict of Interest

Maria Nikoloudi, Ioanna Eleftheriadou, Anastasios Tentolouris, Ourania Kosta, and Nikolaos Tentolouris declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Skin, Soft Tissue, Bone and Joint Infectious Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nikoloudi, M., Eleftheriadou, I., Tentolouris, A. et al. Diabetic Foot Infections: Update on Management. Curr Infect Dis Rep 20, 40 (2018). https://doi.org/10.1007/s11908-018-0645-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11908-018-0645-6

Keywords

Search

Navigation